TY - JOUR
T1 - Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort
AU - Bruce, Ian N.
AU - O'Keeffe, Aidan G.
AU - Farewell, Vern
AU - Hanly, John G.
AU - Manzi, Susan
AU - Su, Li
AU - Gladman, Dafna D.
AU - Bae, Sang-Cheol
AU - Sanchez-Guerrero, Jorge
AU - Romero-Diaz, Juanita
AU - Gordon, Caroline
AU - Wallace, Daniel J.
AU - Clarke, Ann E.
AU - Bernatsky, Sasha
AU - Ginzler, Ellen M.
AU - Isenberg, David A.
AU - Rahman, Anisur
AU - Merrill, Joan T.
AU - Alarcón, Graciela S.
AU - Fessler, Barri J.
AU - Fortin, Paul R.
AU - Petri, Michelle
AU - Steinsson, Kristjan
AU - Dooley, Mary Anne
AU - Khamashta, Munther A.
AU - Ramsey-Goldman, Rosalind
AU - Zoma, Asad A.
AU - Sturfelt, Gunnar K.
AU - Nived, Ola
AU - Aranow, Cynthia
AU - Mackay, Meggan
AU - Ramos-Casals, Manuel
AU - van Vollenhoven, Ronald F.
AU - Kalunian, Kenneth C.
AU - Ruiz-Irastorza, Guillermo
AU - Lim, Sam
AU - Kamen, Diane L.
AU - Peschken, Christine A.
AU - Inanc, Murat
AU - Urowitz, Murray B.
PY - 2015
Y1 - 2015
N2 - Background and aims We studied damage accrual and factors determining development and progression of damage in an international cohort of systemic lupus erythematosus (SLE) patients. Methods The Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort recruited patients within 15 months of developing four or more 1997 American College of Rheumatology (ACR) criteria for SLE; the SLICC/ACR damage index (SDI) was measured annually. We assessed relative rates of transition using maximum likelihood estimation in a multistate model. The Kaplan-Meier method estimated the probabilities for time to first increase in SDI score and Cox regression analysis was used to assess mortality. Results We recruited 1722 patients; mean (SD) age 35.0 (13.4) years at cohort entry. Patients with damage at enrolment were more likely to have further worsening of SDI (SDI 0 vs >= 1; p <0.001). Age, USA African race/ethnicity, SLEDAI-2K score, steroid use and hypertension were associated with transition from no damage to damage, and increase(s) in pre-existing damage. Male gender (relative transition rates (95% CI) 1.48 (1.06 to 2.08)) and USA Caucasian race/ethnicity (1.63 (1.08 to 2.47)) were associated with SDI 0 to >= 1 transitions; Asian race/ethnicity patients had lower rates of new damage (0.60 (0.39 to 0.93)). Antimalarial use was associated with lower rates of increases in pre-existing damage (0.63 (0.44 to 0.89)). Damage was associated with future mortality (HR (95% CI) 1.46 (1.18 to 1.81) per SDI point). Conclusions Damage in SLE predicts future damage accrual and mortality. We identified several potentially modifiable risk factors for damage accrual; an integrated strategy to address these may improve long-term outcomes
AB - Background and aims We studied damage accrual and factors determining development and progression of damage in an international cohort of systemic lupus erythematosus (SLE) patients. Methods The Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort recruited patients within 15 months of developing four or more 1997 American College of Rheumatology (ACR) criteria for SLE; the SLICC/ACR damage index (SDI) was measured annually. We assessed relative rates of transition using maximum likelihood estimation in a multistate model. The Kaplan-Meier method estimated the probabilities for time to first increase in SDI score and Cox regression analysis was used to assess mortality. Results We recruited 1722 patients; mean (SD) age 35.0 (13.4) years at cohort entry. Patients with damage at enrolment were more likely to have further worsening of SDI (SDI 0 vs >= 1; p <0.001). Age, USA African race/ethnicity, SLEDAI-2K score, steroid use and hypertension were associated with transition from no damage to damage, and increase(s) in pre-existing damage. Male gender (relative transition rates (95% CI) 1.48 (1.06 to 2.08)) and USA Caucasian race/ethnicity (1.63 (1.08 to 2.47)) were associated with SDI 0 to >= 1 transitions; Asian race/ethnicity patients had lower rates of new damage (0.60 (0.39 to 0.93)). Antimalarial use was associated with lower rates of increases in pre-existing damage (0.63 (0.44 to 0.89)). Damage was associated with future mortality (HR (95% CI) 1.46 (1.18 to 1.81) per SDI point). Conclusions Damage in SLE predicts future damage accrual and mortality. We identified several potentially modifiable risk factors for damage accrual; an integrated strategy to address these may improve long-term outcomes
U2 - https://doi.org/10.1136/annrheumdis-2013-205171
DO - https://doi.org/10.1136/annrheumdis-2013-205171
M3 - Article
C2 - 24834926
SN - 0003-4967
VL - 74
SP - 1706
EP - 1713
JO - Annals of the rheumatic diseases
JF - Annals of the rheumatic diseases
IS - 9
ER -